Symbol
Arvinas, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$6.56
Current price of the stock
$3M
Trading volume of the stock
$471.7M
Market capitalization of the company
Small Cap
Category of market capitalization
1.27%
Long-term growth mean estimate
4.55
Mean analyst rating
503.83%
Potential price appreciation based on analyst price targets
41.12%
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
0.00
Total debt to total equity ratio
4.64
Current ratio
100.00%
Gross profit margin
-94.99%
Operating profit margin
-94.99%
Earnings before interest and taxes (EBIT) margin
-99.01%
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-75.28%
Pretax profit margin
-75.51%
Net profit margin
-35.41%
Measures profitability relative to shareholders' equity
-35.41%
ROE excluding intangible assets
-18.22%
Measures profitability relative to total assets
-35.37%
Measures profitability relative to invested capital
0.24
Asset turnover ratio
-
Inventory turnover ratio
19.23
Receivables turnover ratio
18.98
Average number of days it takes to collect receivables
-2.37
Measures valuation relative to earnings
-1.76
P/E based on future earnings estimates
1.79
Measures valuation relative to sales
0.80
Measures valuation relative to book value
-0.81
Measures valuation relative to operating cash flow
-0.81
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
